CBIO vs PULM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

CBIO

52.3
AI Score
VS
CBIO Wins

PULM

46.6
AI Score

Investment Advisor Scores

CBIO

52score
Recommendation
HOLD

PULM

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO PULM Winner
Revenue 1.04M 7.80M PULM
Net Income -48.12M -7.57M PULM
Net Margin -4631.4% -97.1% PULM
Operating Income -51.09M -7.81M PULM
ROE -29.5% -69.3% CBIO
ROA -26.3% -65.8% CBIO
Total Assets 182.76M 11.51M CBIO
Cash 171.59M 10.78M CBIO
Current Ratio 9.66 19.40 PULM
Free Cash Flow -28.56M -9.85M PULM

Relative Price Performance (Last 90 Days)

CBIO 1M: -10.7% · 3M: -24.9% PULM 1M: -12.0% · 3M: -10.9%

Current Technical Phase

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 39

RSI (14): 38.6 · Price: $12.72

PULM

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.0%) with fading momentum, RSI 50

RSI (14): 49.6 · Price: $1.47

Fundamentals Snapshot

Metric CBIO PULM
Market Cap — —
Forward P/E -4.9 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin 1.0% -12.7%
Operating Margin -14.3% 0.0%
EPS -7.62 -1.10
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.